138 related articles for article (PubMed ID: 32410390)
1. Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy.
Chrastina A; Welsh J; Rondeau G; Abedinpour P; Borgström P; Baron VT
ChemMedChem; 2020 Jul; 15(14):1338-1347. PubMed ID: 32410390
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
[No Abstract] [Full Text] [Related]
5. The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.
Abedinpour P; Baron VT; Chrastina A; Welsh J; Borgström P
Prostate; 2013 Apr; 73(5):489-99. PubMed ID: 22996809
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
Tripathi SK; Rengasamy KRR; Biswal BK
Arch Pharm Res; 2020 Feb; 43(2):242-256. PubMed ID: 32034669
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Tripathi SK; Panda M; Biswal BK
Food Chem Toxicol; 2019 Mar; 125():566-582. PubMed ID: 30685472
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
10. Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.
Gou Y; Zhang Y; Qi J; Kong L; Zhou Z; Liang S; Yang F; Liang H
Chem Biol Drug Des; 2015 Sep; 86(3):362-9. PubMed ID: 25534036
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
13. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin: A Potential Anti-cancer Compound.
Roy A
Mini Rev Med Chem; 2021; 21(6):731-737. PubMed ID: 33200707
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.
Srinivas P; Patra CR; Bhattacharya S; Mukhopadhyay D
Int J Nanomedicine; 2011; 6():2113-22. PubMed ID: 22114475
[TBL] [Abstract][Full Text] [Related]
18. Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches.
Jamal MS; Parveen S; Beg MA; Suhail M; Chaudhary AG; Damanhouri GA; Abuzenadah AM; Rehan M
PLoS One; 2014; 9(2):e87309. PubMed ID: 24586269
[TBL] [Abstract][Full Text] [Related]
19. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.
Zhang XQ; Yang CY; Rao XF; Xiong JP
Eur J Gynaecol Oncol; 2016; 37(1):30-5. PubMed ID: 27048106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
